All News EuBiologics Co., Ltd.

Equities

A206650

KR7206650004

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
12,360 ^KRW	+1.73%		+0.16%	+7.76%

01-29	Zimbabwe launches door-to-door cholera vaccination campaign	RE
2023	Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EuBiologics co.,Ltd - SNAP Platform enters Phase I clinical studies for RSV	05-13	AQ
Gavi and UNICEF welcome approval of new oral cholera vaccine	04-19	AQ
Gavi and Unicef Welcome Approval of New Oral Cholera Vaccine [press release]	04-19	AQ
What's Behind the Worldwide Shortage of Cholera Vaccines? for Starters, They're Only Made By One Company [analysis]	03-13	AQ
Zimbabwe launches door-to-door cholera vaccination campaign	01-29	RE
Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	14/07/23	CI
Gavi - Global vaccine alliance outlines path to sustainable cholera vaccine supply	23/05/23	AQ
EuBiologics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23	CI
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19	01/12/22	AQ
POP Biotechnologies' next-gen vaccine technology to enter COVID-19 phase III clinical trials	07/02/22	AQ
Eubiologics Co., Ltd. Announces Phase Iii Clinical Trial Ind Approval of Eucorvac-19, Covid-19 Vaccine Candidate, in South Korea	03/02/22	CI
Clips Co., Ltd. announced that it expects to receive KRW 2.50003 billion in funding from EuBiologics Co., Ltd., SK bioscience Co.,Ltd., BNC Korea Co., Ltd.	26/01/22	CI
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12/04/21	RE
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea	21/01/21	CI
EuBiologics Co., Ltd.(KOSDAQ:A206650) added to S&P Global BMI Index	23/09/19	CI
ATGC Co., Ltd. announced that it has received KRW 2.1 billion in funding from EuBiologics Co., Ltd.	09/01/19	CI
ATGC Co., Ltd. announced that it expects to receive KRW 2.1 billion in funding from EuBiologics Co., Ltd.	03/01/19	CI
EuBiologics Co., Ltd. announced that it has received KRW 30.00000351 billion in funding	29/04/18	CI
EuBiologics Co., Ltd. announced that it expects to receive KRW 30 billion in funding	11/02/18	CI
Global Health Investment Fund I, LLC, managed by Global Health Investment Advisors, LLC acquired 6.19% stake in EuBiologics Co., Ltd..	01/02/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News EuBiologics Co., Ltd.

Equities

A206650

KR7206650004

All News

Filters